Literature DB >> 21501621

Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.

Bryce Chackerian1, Jerri do Carmo Caldeira, Julianne Peabody, David S Peabody.   

Abstract

Filamentous phages are now the most widely used vehicles for phage display and provide efficient means for epitope identification. However, the peptides they display are not very immunogenic because they normally fail to present foreign epitopes at the very high densities required for efficient B-cell activation. Meanwhile, systems based on virus-like particles (VLPs) permit the engineered high-density display of specific epitopes but are incapable of peptide library display and affinity selection. We developed a new peptide display platform based on VLPs of the RNA bacteriophage MS2. It combines the high immunogenicity of MS2 VLPs with the affinity selection capabilities of other phage display systems. Here, we describe plasmid vectors that facilitate the construction of high-complexity random sequence peptide libraries on MS2 VLPs and that allow control of the stringency of affinity selection through the manipulation of display valency. We used the system to identify epitopes for several previously characterized monoclonal antibody targets and showed that the VLPs thus obtained elicit antibodies in mice whose activities mimic those of the selecting antibodies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21501621      PMCID: PMC3095728          DOI: 10.1016/j.jmb.2011.03.072

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  26 in total

1.  CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases.

Authors:  Federico Perosa; Elvira Favoino; Maria Antonietta Caragnano; Franco Dammacco
Journal:  Ann N Y Acad Sci       Date:  2005-06       Impact factor: 5.691

2.  Mimotope vaccination for epitope-specific induction of anti-CD20 antibodies.

Authors:  Meng Li; Zhen Yan; Wei Han; Yingqi Zhang
Journal:  Cell Immunol       Date:  2006-06-30       Impact factor: 4.868

Review 3.  Virus-like particles: flexible platforms for vaccine development.

Authors:  Bryce Chackerian
Journal:  Expert Rev Vaccines       Date:  2007-06       Impact factor: 5.217

4.  Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides.

Authors:  W P Stemmer; A Crameri; K D Ha; T M Brennan; H L Heyneker
Journal:  Gene       Date:  1995-10-16       Impact factor: 3.688

5.  Subunit fusion confers tolerance to peptide insertions in a virus coat protein.

Authors:  D S Peabody
Journal:  Arch Biochem Biophys       Date:  1997-11-01       Impact factor: 4.013

6.  Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies.

Authors:  Angelika B Riemer; Harald Kurz; Markus Klinger; Otto Scheiner; Christoph C Zielinski; Erika Jensen-Jarolim
Journal:  J Natl Cancer Inst       Date:  2005-11-16       Impact factor: 13.506

7.  The epitope recognized by rituximab.

Authors:  Mascha Binder; Florian Otto; Roland Mertelsmann; Hendrik Veelken; Martin Trepel
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

8.  The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.

Authors:  Jun Zhang; Junjie Xu; Guanlin Li; Dayong Dong; Xiaohong Song; Qiang Guo; Jian Zhao; Ling Fu; Wei Chen
Journal:  Biochem Biophys Res Commun       Date:  2006-01-26       Impact factor: 3.575

9.  The RNA binding site of bacteriophage MS2 coat protein.

Authors:  D S Peabody
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

10.  Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen.

Authors:  Michael J Gubbins; Jody D Berry; Cindi R Corbett; Jeremy Mogridge; Xin Y Yuan; Lisa Schmidt; Brigitte Nicolas; Amin Kabani; Raymond S Tsang
Journal:  FEMS Immunol Med Microbiol       Date:  2006-08
View more
  28 in total

Review 1.  Malaria invasion ligand RH5 and its prime candidacy in blood-stage malaria vaccine design.

Authors:  Rosalynn L Ord; Marilis Rodriguez; Cheryl A Lobo
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.

Authors:  John P O'Rourke; David S Peabody; Bryce Chackerian
Journal:  Curr Opin Virol       Date:  2015-03-29       Impact factor: 7.090

3.  Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles.

Authors:  Carlee E Ashley; Eric C Carnes; Genevieve K Phillips; Paul N Durfee; Mekensey D Buley; Christopher A Lino; David P Padilla; Brandy Phillips; Mark B Carter; Cheryl L Willman; C Jeffrey Brinker; Jerri do Carmo Caldeira; Bryce Chackerian; Walker Wharton; David S Peabody
Journal:  ACS Nano       Date:  2011-06-07       Impact factor: 15.881

4.  Evolution of a designed protein assembly encapsulating its own RNA genome.

Authors:  Gabriel L Butterfield; Marc J Lajoie; Heather H Gustafson; Drew L Sellers; Una Nattermann; Daniel Ellis; Jacob B Bale; Sharon Ke; Garreck H Lenz; Angelica Yehdego; Rashmi Ravichandran; Suzie H Pun; Neil P King; David Baker
Journal:  Nature       Date:  2017-12-13       Impact factor: 49.962

5.  Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirus.

Authors:  Chean Yeah Yong; Swee Keong Yeap; Zee Hong Goh; Kok Lian Ho; Abdul Rahman Omar; Wen Siang Tan
Journal:  Appl Environ Microbiol       Date:  2014-11-21       Impact factor: 4.792

Review 6.  Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.

Authors:  Francis B Ntumngia; Christopher L King; John H Adams
Journal:  Int J Parasitol       Date:  2012-10-12       Impact factor: 3.981

7.  Controlled integration of gold nanoparticles and organic fluorophores using synthetically modified MS2 viral capsids.

Authors:  Stacy L Capehart; Michael P Coyle; Jeff E Glasgow; Matthew B Francis
Journal:  J Am Chem Soc       Date:  2013-02-12       Impact factor: 15.419

Review 8.  Engineering virus-like particles as vaccine platforms.

Authors:  Kathryn M Frietze; David S Peabody; Bryce Chackerian
Journal:  Curr Opin Virol       Date:  2016-03-29       Impact factor: 7.090

9.  The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine.

Authors:  Mitchell Tyler; Ebenezer Tumban; David S Peabody; Bryce Chackerian
Journal:  Biotechnol Bioeng       Date:  2014-07-31       Impact factor: 4.530

10.  Identification of Anti-CA125 Antibody Responses in Ovarian Cancer Patients by a Novel Deep Sequence-Coupled Biopanning Platform.

Authors:  Kathryn M Frietze; Richard B S Roden; Ji-Hyun Lee; Yang Shi; David S Peabody; Bryce Chackerian
Journal:  Cancer Immunol Res       Date:  2015-11-20       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.